Sprout Health review

What it is

Sprout Health Partners LLC, based in Encinitas, California, runs a cash-pay telehealth service for compounded GLP-1 weight loss and compounded NAD⁺. Clinical care comes from MD Integrations, a physician-only clinical network, and the terms list Foothills Pharmacy and Promise Pharmacy as its dispensing pharmacies. It serves Alaska, Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming, and not Alabama, Arkansas, California, Louisiana, Mississippi or North Dakota. It shows a LegitScript logo in its footer and says it has served more than 20,000 customers since 2025.

How it works

You take a pre-qualification quiz, buy a plan, and then complete a more detailed medical questionnaire that a licensed clinician reviews. If the clinician decides you aren't a candidate, the order is canceled and refunded. If you are, the prescription goes to a partner pharmacy, and Sprout says most prescriptions are sent within two business days of your visit and orders typically ship within three to seven business days. Most states are handled by questionnaire, but MD Integrations doctors hold a live visit where state law requires one: Colorado, Idaho, Illinois, Indiana, Maryland, Missouri, Montana, Nebraska, New York, Oklahoma, South Dakota, Vermont, Virginia and Wisconsin. Refills are gated. After each renewal charge you fill out a new questionnaire, and the pharmacy ships only after your clinician approves it; you become eligible after your third dose of the current cycle, and dose increases are your clinician's call. You message your clinician through a medical portal, and customer support runs by phone and email on weekdays. If you've used a GLP-1 before and want to continue at your current dose, tell the doctor before the prescription is issued.

Pricing transparency

Semaglutide is $149 per four weeks month-to-month, or $99 a month on a 12-month plan billed $1,188 up front. Tirzepatide is $199 per four weeks month-to-month, or $149 a month on a 12-month plan billed $1,788. Because the monthly plan bills every four weeks, a year of semaglutide month-to-month costs about $1,937, and a year of tirzepatide about $2,587. Sprout's refund policy also mentions three- and six-month plans, and its how-it-works page describes quarterly billing, where a GLP-1 order ships a two-month supply at a time; ask which plan lengths are on offer when you check out. Plans renew automatically until you pause or cancel, and cancellations need 48 hours' notice before the billing date. Refunds depend on timing: a full refund before a provider reviews your intake, the charge minus a $50 clinical review fee after review but before the prescription reaches the pharmacy, and nothing once it has. If you cancel a prepaid plan early, Sprout refunds the per-month value you actually paid for each month not yet shipped. Compounded NAD⁺ is $249 a month, with $50 off the first month.

Branded vs compounded

Compounded semaglutide and tirzepatide, and compounded NAD⁺, from licensed U.S. pharmacies. Sprout's disclosure is direct: compounded semaglutide and tirzepatide "are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality by the FDA," and "are not brand name drugs nor are they considered to be generics." Brand-name GLP-1s aren't part of its offer. The weight-loss trial results belong to the branded drugs, and compounded versions haven't been through those trials. For NAD⁺, Sprout makes no outcome claim beyond calling it a prescription option your clinician may consider, which is the honest position: injected NAD⁺ has no controlled human outcome trials.

Pros and watch-outs

The evidence behind what Sprout Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• NAD+ injections: benefits, side effects, cost and what the evidence says

  Subcutaneous NAD+ is sold as a cheaper, at-home alternative to the IV drip, through “near me” clinics or telehealth shipped to your door. It’s compounded, not FDA-approved, and has no outcome trials; oral NR/NMN precursors are the route with the human data.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How Sprout Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• MEMEDGm

  Readers who want compounded and brand-name GLP-1 routes presented side by side

  See MEDGm →
• Willow

  Buyers who want every dose priced and the pharmacies named, and will pay more for it

  See Willow →
• Breeze Meds

  Compounded GLP-1 with named-pharmacy transparency

  See Breeze Meds →

Head-to-head: Sprout Health vs Ro · Sprout Health vs Mochi Health · Sprout Health vs LifeMD · Sprout Health vs Form Health · Sprout Health vs PlushCare

More GLP-1 telehealth reviews: Rx.com · No BS RX · Idgie Health · Renlo Health · Prime Doctor RX · Edessa